Targeting eosinophils by active vaccination against interleukin-5 reduces basophil counts in horses with insect bite hypersensitivity in the 2nd year of vaccination.

This research examines if a specialized vaccine targeting interleukin-5 (a type of protein that plays a crucial role in the life cycle of white blood cells) can effectively decrease the count of basophils (a type of white blood cell) in horses suffering from insect bite hypersensitivity. The study discovered a significant reduction in basophils, especially in the third year, after administering the anti-interleukin-5 vaccine.

Research Studies and Experiments

• The research study used a virus-like particle (VLP)-based self-vaccinations that target interleukin (IL)-5 or IL-31, which are proteins that play significant roles in the regulation of immune responses.
• These targeted vaccinations were previously proposed as treatment options for equine insect bite hypersensitivity (IBH), a recurring seasonal allergic skin reaction in horses.

Evaluation and Findings

• The objective of this study was to assess whether an equine anti-IL-5 vaccine can influence blood basophil counts (a type of white blood cell involved in allergic responses) in horses.
• The research followed horses with IBH over a three-year trial with the first year seeing a placebo administration, followed by the application of an equine (e)IL-5-VLP vaccine in the second and third years.

Outcomes (2nd and 3rd years of Vaccine Administration)

• The outcomes showed a significant reduction in circulating eosinophil counts (another type of white blood cell) after the administration of the vaccine against IL-5.
• The study also recorded reductions in basophil counts but this reduction was predominantly seen in the third year of the study.
• This suggests a potential bystander effect of the anti-IL-5 vaccine on basophil counts, indicating that the vaccine might indirectly decrease basophil count while directly targeting eosinophils.